Back to search

Article

Pan-transcriptome-based Candidate Therapeutic Discovery for Idiopathic Pulmonary Fibrosis

2019-10-30

Abstract excerpt

<h4>ABSTRACT</h4> <h4>BACKGROUND</h4> Although the advent of two FDA-approved therapies for idiopathic pulmonary fibrosis (IPF) has energized the field, their effects are largely suppressive than pulmonary fibrosis remission- or reversion-inducing. Hence, the pursuit for newer IPF therapeutics continues. Recent studies show that joint analysis of systems biology level information with drug-disease connectivity a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b339c46d-86d4-53b8-bcfc-4e55874518d0
DOI
10.1101/824367
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pan-transcriptome-based Candidate Therapeutic Discovery for Idiopathic Pulmonary FibrosisDOI 10.1101/824367
Select a neighboring publication to make it the new centre.